Concepedia

Glucagon-like peptide 1 receptor agonists and the potential risk of pancreatic carcinoma: a pharmacovigilance study using the FDA Adverse Event Reporting System and literature visualization analysis

Mingnan Cao, Chen Pan, Yue Tian, Li Wang, Zhigang Zhao, Bin Zhu

International Journal of Clinical Pharmacy · 2023 · 15 citations · 19 references

DOI

Concepts

References

19

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Melanie J. Davies, David A. D’Alessio, Judith Fradkin et al. · Diabetes Care · 2018 · 3.4K citations · Full text

Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies

Michael Elashoff, Aleksey V. Matveyenko, Belinda Gier et al. · Gastroenterology · 2011 · 911 citations · Full text

, , +4

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

Carolyn F. Deacon, Michael A. Nauck, Lone Pridal et al. · Diabetes · 1995 · 649 citations

Truncated glucagon‐like peptide I, an insulin‐releasing hormone from the distal gut

Jens J. Holst, Cathrine Ørskov, O. Vagn Nielsen et al. · FEBS Letters · 1987 · 602 citations · Full text

, , +18

Management of Hyperglycemia in Type 2 Diabetes

NEIL SKOLNIK, CURTIS OLSON · Family Practice News · 2012 · 524 citations

, , +2